What Is Ashwagandha

Ashwagandha (Withania somnifera) is a perennial shrub in the nightshade family, native to the Indian subcontinent and parts of Africa, whose root has been used for centuries in Ayurvedic medicine as a rejuvenative tonic. Its primary bioactive compounds, a group of steroidal lactones called withanolides, interact with the neuroendocrine and immune systems. In modern supplementation, ashwagandha is classified as an adaptogen, meaning it is proposed to help the body resist and recover from various forms of physiological stress.

Chronic psychological stress accelerates biological aging through several converging mechanisms: sustained cortisol elevation degrades hippocampal neurons, suppresses immune surveillance, impairs glucose metabolism, and shortens telomeres. Any intervention that reliably moderates the cortisol response without blunting it entirely has relevance to healthspan. Ashwagandha sits at this intersection because its mechanism of action centers on the hypothalamic-pituitary-adrenal (HPA) axis, the body's primary stress command system.

Beyond cortisol, ashwagandha influences pathways that are independently relevant to aging. It modulates inflammatory cytokines, supports thyroid hormone production, and may enhance mitochondrial function. Its effects on sleep quality also matter, since poor sleep is both a driver and a consequence of HPA axis dysregulation. For these reasons, ashwagandha appears repeatedly in longevity-oriented supplement stacks, though its value depends heavily on the individual's stress burden, hormonal baseline, and the quality of the extract being used.

Ashwagandha's withanolides interact with multiple receptor systems and signaling pathways. The most studied mechanism involves modulation of the HPA axis. Under chronic stress, the hypothalamus releases corticotropin-releasing hormone (CRH), which triggers the pituitary to secrete adrenocorticotropic hormone (ACTH), which in turn stimulates the adrenal cortex to produce cortisol. Withanolides appear to attenuate this cascade at multiple points, reducing the magnitude and duration of cortisol release without abolishing the stress response entirely. Animal models suggest that withaferin A and withanolide A also upregulate GABA receptor activity, which contributes to the herb's calming and sleep-promoting effects.

Ashwagandha also acts on the immune system through two parallel pathways. It enhances natural killer cell activity and macrophage function (innate immunity) while modulating T-cell profiles and reducing pro-inflammatory cytokines such as TNF-alpha and IL-6. This dual action, stimulating defense while tempering inflammation, distinguishes it from simple immunostimulants. Some in vitro evidence suggests withaferin A can inhibit NF-kB, a master transcription factor that drives inflammatory gene expression.

At the cellular level, ashwagandha has shown effects on mitochondrial enzyme activity and antioxidant defenses, particularly superoxide dismutase and catalase. There is also preliminary evidence from cell culture and animal studies that certain withanolides support neurite outgrowth and synaptic plasticity, which may explain the cognitive improvements observed in some human trials. These mechanisms are interconnected: reducing cortisol protects neurons, supporting mitochondria improves energy for immune function, and calming the nervous system improves sleep, which in turn facilitates repair across all systems.

Ashwagandha is available as a raw root powder, an encapsulated root extract, a liquid tincture, and increasingly in gummy and drink-mix formats. Raw root powder retains the full spectrum of plant compounds but has lower withanolide concentration per gram and an earthy, somewhat bitter taste. Standardized extracts, concentrated through water or hydroethanolic extraction, deliver a reliable withanolide dose in a smaller volume and are the form used in nearly all clinical trials.

The two most researched standardized forms are KSM-66 (root-only extract, typically standardized to at least 5% withanolides by HPLC) and Sensoril (root-and-leaf extract, standardized to at least 10% withanolides and 32% oligosaccharides). These are not interchangeable, as the inclusion of leaf material in Sensoril introduces withaferin A at higher concentrations, which contributes to its stronger anti-inflammatory and sedative profile. Capsules remain the most practical delivery method for dosing accuracy. Liquid tinctures can offer faster absorption but are harder to dose precisely, and many commercial tinctures use unstandardized material.

Clinical trial doses for standardized root extracts typically range from 300 to 600 mg per day, with some studies using up to 1,000 mg. For KSM-66, most positive outcomes have been observed at 600 mg daily, split into two doses of 300 mg. For Sensoril, effective doses tend to be somewhat lower (125 to 250 mg) due to its higher withanolide concentration. When using unstandardized root powder, traditional Ayurvedic doses range from 3 to 6 grams per day, though these larger amounts may cause more gastrointestinal discomfort.

Timing matters depending on the target outcome. For sleep support, a single dose taken 30 to 60 minutes before bed aligns with its GABAergic and cortisol-lowering activity. For daytime stress resilience or physical performance, a morning dose (or split morning and midday dosing) is more appropriate. Starting at the lower end of the dose range and titrating up over a week or two allows assessment of individual tolerance. Because ashwagandha modulates receptor systems over time rather than producing acute effects, a minimum trial of six weeks is necessary before judging efficacy.

The most important quality marker for an ashwagandha supplement is third-party verification of withanolide content, since the bioactivity of the product depends directly on the concentration of these compounds. Look for products that specify withanolide percentage on the label and ideally carry a certificate of analysis (COA) from an independent lab. Products using KSM-66 or Sensoril branded extracts are inherently more traceable, as both suppliers maintain quality control at the manufacturing level.

Contamination is a legitimate concern with botanicals sourced from the Indian subcontinent. Heavy metals (lead, arsenic, mercury, cadmium) and pesticide residues have been detected in some ashwagandha products in independent testing. USP, NSF International, or Informed Sport certifications provide an additional layer of assurance that the product has been tested for contaminants. Avoid products that list only "ashwagandha" without specifying whether the material is root, leaf, or a blend, as withanolide profiles differ substantially between plant parts, and some lower-cost products use aerial parts to cut costs.

Ashwagandha has a larger body of human clinical evidence than most botanical supplements. Multiple randomized, double-blind, placebo-controlled trials have examined its effects on perceived stress, serum cortisol, sleep quality, testosterone, and cognitive function. Across stress and cortisol outcomes, results are fairly consistent: most trials report statistically significant reductions in self-reported stress and measurable cortisol decreases, though effect sizes vary. Sleep trials similarly show improvements in subjective quality and sleep onset latency, particularly in populations with baseline insomnia or stress-related sleep disturbance.

The evidence for testosterone enhancement is more mixed. Some trials in stressed or subfertile men show modest increases, but studies in healthy, unstressed men are less consistent. Cognitive outcomes (memory, reaction time, attention) have appeared in several trials, though sample sizes have been small and populations heterogeneous. Notably, most positive trials have used standardized extracts (KSM-66 or Sensoril) at doses between 300 and 600 mg per day over 8 to 12 weeks. Trials using unstandardized powders or very short durations have produced weaker or null results. Long-term safety data beyond 12 weeks of continuous use is limited, and most trials have been conducted in Indian populations, raising questions about generalizability. Systematic reviews generally support the cortisol and stress findings while noting that more rigorous, larger-scale replication is still needed.

Ashwagandha is generally well tolerated at standard doses, with gastrointestinal discomfort, drowsiness, and mild headache as the most commonly reported side effects. Because it can stimulate thyroid hormone production, individuals with hyperthyroidism or those taking levothyroxine should be cautious. Ashwagandha may have immunomodulatory effects that are contraindicated for people on immunosuppressive therapy or those with autoimmune conditions where immune activation is harmful. Rare case reports have linked high-dose or prolonged use to liver enzyme elevations, though causality is difficult to establish. Pregnant and breastfeeding individuals should avoid it, as traditional texts classify it as a potential abortifacient at high doses. As with any supplement that modulates hormonal axes, interactions with medications affecting the endocrine system (thyroid drugs, corticosteroids, sedatives, anxiolytics) should be considered.